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Abstract
Background: Process formation by glial cells is crucial to their function. Mayven, an actin binding, multi-domain 
polypeptide, and member of the BTB-BACK-Kelch family have been shown to be important in oligodendrocyte process 
extension. To assess the role of Mayven in neural cell process extension we have tracked the subcellular distribution of 
exogenous Mayven following expression of a rat Mayven -EGFP cDNA in a variety of neural cell backgrounds and 
specifically in OEC tranfectants following drug treatment to disrupt the integrity of the cytoskeleton. A comparison was 
made between the subcellular localization following transient transfection of OECs with full-length Mayven cDNA and 
a series of mutant domain constructs.
Results: The subcellular location of Mayven in OEC transfectants showed a characteristic distribution with intense foci 
of staining towards the process tips corresponding to regions of accumulated Mayven overlapping in part with 
lammelipodial actin and was absent from the filipodia and the outer membrane. This signature pattern was also 
observed in Schwann cells, Oli-Neu cells, astrocytes and the neuroblastoma cell line B104 transfectants and resembled 
the exogenous and endogenous Mayven distribution in oligodendrocytes. This contrasted with the localization 
pattern in non-neural cells. There was a re-localization of Mayven in OEC transfectants following drug treatment to 
challenge the integrity of the actin cytoskeleton while breakdown of the microtubular component had no discernible 
impact on the accumulation of Mayven in the process tips. Deletion of the first three amino acids of the SH3 motif of 
the putative Fyn Kinase binding domain at the amino terminus significantly compromised this signature pattern as did 
the removal of the last Kelch repeat unit of six unit Kelch domain comprising the carboxyl terminus. In addition, there 
was a reduction in process length in mutant transfectants. Co-expression studies with a haemagglutinin (HA) tagged 
wild type Mayven cDNA and EGFP tagged mutant cDNAs suggested a homomeric interaction mediated by the BTB/
POZ domain.
Conclusions: Exogenous Mayven is transported to the lamellipodia in neural transfectants associating with the actin 
cytoskeletal network. In addition to the importance of the internal BTB/POZ domain, this subcellular distribution 
pattern is dependent on the presence of an intact amino and carboxyl terminus.
Background
Actin polymerization driven membrane protrusion, ini-
tially results in the formation of fine filipodia projections
comprising parallel actin bundles. The filipodia widen to
form lamellipodia by creating a branched mesh network
of orthogonal actin. Consequent recruitment of microtu-
bules provides mechanical stability to the extending
lamellipodia. This is a common mechanism shared by a
range of process bearing cell types [1] including oligoden-
droglia [2] and olfactory ensheathing cells (OECs) [3,4].
The exact mechanisms by which cells extend processes
and carry out complex cell:cell interactions, for example
how oligodendrocytes enwrap axons and form myelin
sheaths are not known. However , it is apparent that to
generate these vast, highly organised membranous exten-
sions, extensive coordinated cytoskeletal remodelling
must occur [5]. Consequently, the contribution of
cytoskeletal dynamics to process extension and axonal
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wrapping is fundamental to myelination. Identifying the
molecules involved and understanding their mechanism
of action is crucial to extend our knowledge of how
myelin formation occurs during development and remy-
elination.
Recently, a candidate protein, Mayven (KLHL2) has
been reported to have a crucial role in the extension of
oligodendrocyte precursor cell (OPC) processes [6,7].
This actin binding protein [8] belongs to the BTB-BACK-
K e l c h  f a m i l y  w i t h  a r o u n d  5 0  m e m b e r s  [ 9 ] .  A l t h o u g h
these proteins are highly conserved at the structural
domain level, they have a wide range of cellular functions
including the stability and dynamics of microfilaments
[10,11]. The predicted 593 residue Mayven polypeptide
has four structural domains (Fig. 1). The presence of a
Fyn Tyrosine Kinase Binding domain (AAs 4-45) includ-
ing the proline rich SH3 ligand motif (AAs 4-10)
(P1P2LP3P4A) is intriguing considering the crucial role
ascribed to Fyn Kinase in myelinogenesis and in differen-
tiation of cultured oligodendrocytes [12,13]. Co-immu-
noprecipitation and GST pull-down experiments confirm
an association between the SH3 motif of Mayven and Fyn
Kinase [7]. The Broad complex, Tramtrac, Bric-a-brac)/
(Poxvirus, Zinc finger (BTB/POZ) domain (AAs 56-123)
can self associate or heteromerize with other BTB/POZ
proteins [14,15]. AAs 124-307 encode a BTB and C-ter-
minal Kelch (BACK) domain with as yet no confirmed
function [16]. The Kelch domain at the carboxyl terminus
(AAs 308-591) is associated F-actin binding [8] and com-
prises six contiguous units forming a characteristic β-
propeller tertiary structure exposing a plethora of contact
sites for interacting side chains of as yet unidentified
binding partners [17]. This domain organization may
favour the formation of a multi-protein complex integral
to cytoskeletal remodelling. A precedent for this has been
reported by laboratory colleagues showing that Krp1, a
BTB-BACK-Kelch family member forms a multi-protein
complex during tumour invasion leading to pseudopodial
elongation. Krp1 binds to the actin binding protein Lasp-
1 at the leading edge of the membrane interacting with an
integrin CD44-adaptor protein Ezrin complex providing
a molecular conduit between the ECM and intracellular
signal transduction [18].
We and others have shown, using immunocytochemis-
try, that Mayven is present in oligodendrocytes and OPC
processes; especially in the retracting end of the cell, the
leading edge of lamellipodia and at intervals along the
length of some processes [6,7]. This pattern correlates
with areas where dynamic reorganisation of actin occurs
and where process formation is ongoing. Using RNA
interference (RNAi) we demonstrated that Mayven has a
role in process extension in OPCs but does not affect
their migration or differentiation [6]. Confirmation of our
siRNA effect was demonstrated by others, who also
showed that over expression of a Mayven cDNA con-
struct in an OPC line led to an increase in both process
outgrowth and average process length, and conversely,
OPC process extension was inhibited following microin-
jection of Mayven antibodies [7]. Earlier, a study by Sol-
tysik-Espanola et al [8], reported co-localization of
endogenous Mayven and cortical actin in U373-MG
astrocytoma/glioblastoma cells in the cell body and along
the processes of rat hippocampal neurons.
In addition to Mayven, other proteins are known to reg-
ulate OPC processes extension. Following engagement by
ECM molecules such as fibronectin and laminin, the dif-
ferentially expressed αvβ1 and αvβ5 integrins can trigger
several signalling cascades by activation of Fyn Kinase
and the small GTPase family members, RhoA, Rac1 and
Cdc42 [19,20] linking extracellular stimuli to changes in
the organization of the cytoskeleton. Activation of the
actin nucleation complex Arp2/3 is the rate limiting step
in actin polymerization driven membrane protrusion [1].
This is mediated in part by binding N-W ASP following
activation by Cdc42 while Rac1 activated WAVE1 binds
to Arp2/3 leading to filipodia and lamellipodia formation
respectively [21]. Like Mayven, these polypeptides have
been shown by immunostaining to localize to the OPC
lamellipodium and the leading edge of Schwann cells [2].
Recently another BTB-BACK-Kelch protein originally
termed KLHL1 [22] that is specifically found in the brain,
is transported to the leading edge in the OPC, where it
co-localizes with actin [23]. Antisense and overexpres-
sion studies suggest a key role for this protein in process
extension. Given the similarity to Mayven, the authors
refer to this protein as Mayven Related Protein 2 (MRP2).
The aims of this study were two fold. First, to explore
the relationship between Mayven and the cytoskeleton by
examining the subcellular localization of EGFP tagged
Mayven following drug treatment to challenge the integ-
rity of the cytoskeletal network. Second, if Mayven does
have a critical role in actin polymerization driven neural
membrane protrusion, the protein is likely to be trans-
ported to its correct site for interaction with as yet
unidentified components of the process extension
machinery. The Fyn Kinase binding domain with its close
association with glial development and myelinogenesis
Figure 1 Domain organization of Mayven. Amino acid positions de-
marcating the individual domains are numbered and the sequence of 
the SH3 motif is highlighted.Montague et al. BMC Neuroscience 2010, 11:63
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[12,13] and the actin binding properties of the Kelch
domain [8] may have functional roles in the regulated
transport and accumulation of Mayven in the process
tips. To identify cognate sequences involved in this pro-
cess, we have tracked the subcellular destination of exog-
enous tagged Mayven following transient transfection of
OECs with a range of amino and carboxyl Mayven
domain mutants. Although this cell type has a highly
dynamic morphology, two distinct morphologies pre-
dominate. Those with a spindle like appearance with long
processes which can extend over considerable distances
and a population with a more flat cell body and shorter
thick processes [24]. Time-lapse imaging studies have
reported that individual OECs continually change their
shape, size and direction of movement [3,4]. In addition,
compared to oligodendroyte lineage cells, OECs have a
high transfection rate. This well established experimental
paradigm can provide insight into the function of the
endogenous counterpart as highlighted in a recent study
which compared the distribution of EGFP tagged wild
type Myelin Protein Zero cDNA to that of several mutant
forms following transient transfection [25].
Methods
Constructs
The 1782 bp rat Mayven cDNA corresponding to the 593
amino acid Open Reading Frame [6] cloned in pPCR-
ScriptCamSK (Stratagene) was used as a template for the
construction of wild type Mayven, a panel of amino and
carboxyl domain deletion mutants and a set of mutants
with a disrupted SH3 motif of the Fyn Kinase binding
domain (Fig. 2(i),(ii),(iii)). Using restriction site anchored
PCR primers pairs (Table 1), amplicons were synthesized
using the proofreading EasyA Polymerase (Stratagene)
which possesses both terminal transferase and exonu-
clease activities to generate high-fidelity PCR products
containing 3'-A overhangs and cloned into the T/A vector
pSC-A (Stratagene). The inserts were released by restric-
tion enzyme digestion and covalently linked in-frame at
the corresponding restriction sites in the Multiple Clon-
ing Site (MCS) of the commercial carboxyl reporter vec-
tor pEGFP-N1 encoding the red-shifted variant of the
green fluorescent protein (EGFP) (BD Biosciences). In
addition, wild type Mayven cDNA was subcloned into the
amino reporter vector pEGFP-C3 (Invitrogen) and pMH
(Roche) encoding a nine amino acid haemagglutinin
(HA) epitope at the carboxyl terminus. Forward primers
for cloning into pEGFP-N1 and pMH in which the
respective reporters are in the carboxyl orientation, con-
t a i n e d  a n  a r t i f i c i a l  K o z a k  s e q u e n c e  t o  i n c r e a s e  f u s i o n
protein levels. As depicted in Table 1, common primers
(see dagger symbol) were used in the construction of the
series of Mayven cDNA mutants. All recombinants were
verified by sequencing to ensure in-frame integrity at the
Mayven-EGFP junction.
pLasp-1-GFP and pLasp-1-Cherry were kindly supplied
by Dr Heather Spence (Beatson Institute). pEGFP-Actin
(BD Biosciences) encodes a fusion protein comprising the
green fluorescent protein cDNA and the human cytoplas-
mic β-actin cDNA.
Reverse Transcription Polymerase Chain Reaction (RT.PCR)
Cells grown on 13 mm PLL coated coverslips or PLL
treated T25 cm2  f l a s k s  w e r e  r i n s e d  o n c e  i n  P B S  a n d
homogenized in 1 ml of RNABee (ams Biotechnology)
and total cellular RNA extracted according to manufac-
turer's guidelines. Random hexamer (Invitrogen) primed
cDNA synthesis was performed on 2 μg of total cellular
RNA prepared from T25 cm2 flasks or 250 ng isolated
from 105 cells seeded onto coverslips using SuperScript
III ™ (Invitrogen) reverse transcriptase following sup-
plier's guidelines. PCRs were carried out on 5 ng of cDNA
using REDTaq ReadyMix PCR Reaction Mix (Sigma).
Routine thermal cycling conditions were as follows: an
initial denaturation step of 94°C/5 mins, a core cycle
comprising (94°C/1 min-55°C/1 min-72°C/1 min) for 25-
35 cycles followed by a final extension of 72°C/10 mins.
Rat primer sequences and product lengths were as
detailed below. β-actin  : Forward (5'-CATTGCT-
GACAGGATGCAGAAGGA-3'), Reverse (5'-ACT-
CATCGTACTCCTGCTTGCTGA-3') product length
146 bps. Cyclophilin  : Forward (5'-ACCCCACCGTGT-
TCTTCGAC-3'), Reverse (5'-CATTTGCCATGGACAA-
GATG-3') product length 300 bps. Mayven : Forward (5'-
ACCCTGTCAACTGCTTAGG-3'), Reverse (5'-GCT-
GAAAATGTCCTTCAGGC-3') product length 1323 bps.
Cyclophilin and β-actin primers were included as internal
controls for invariant gene expression. PCR products
were visualised on ethidium bromide stained 2% agarose
gels and images captured on an UVIdocD55XD system
(Uvitec UK).
Cell culture and transfection
A range of neural cell types were used. An OPC line gen-
erated from the optic nerve of 7-day old rat pups [26] was
immortalised with the c-myc gene (O2A-cmyc) and
maintained as OPCs in 40% B104 conditioned medium/
SATO (neuroblastoma cells that secrete growth factors
that promote OPC proliferation [27] or PDGF and FGF2
20 ng/ml of each (Peprotech UK). These cells (referred to
as OPCs) differentiate after the removal of growth factors
with the subsequent elaboration of many processes typi-
cal of mature oligodendrocytes [26,28]. The second OPC
line used, referred to as rat Oli-Neu were grown in 1-2%
horse serum/SATO [29]. We also studied glial cells that
had a larger cytoplasm with more visible cytoskeletal pro-
teins, eg rat olfactory ensheathing cells (OECs,) [24] andMontague et al. BMC Neuroscience 2010, 11:63
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cortical astrocytes which were isolated and maintained as
previously described [30]. B104 cells grown in 10% FBS/
DMEM were also used. Two non-neural cell types were
used for comparison; Cos7 and BHK fibroblasts which
were maintained in 10%FBS/DMEM. Neural cells
selected for transient transfections were plated onto poly-
L-Lysine (PLL, 13 μg ml-1 Sigma, Poole UK) coated 13
mm glass coverslips at a sub confluent cell density and
incubated overnight in their appropriate medium. The
following day 0.5 μg plasmid DNA transient transfections
were performed using Lipofectomine (Ltx) in conjunc-
tion with PLUS reagent following the manufacturer's
guidelines (Invitrogen, UK). Exposure times to the Ltx
complex varied from four hrs to overnight dependent on
Figure 2 Subcellular distribution pattern of exogenous Mayven following expression of a panel of pMayven-EGFP mutants. Group (I) Ami-
no mutants, Group (II) Carboxyl mutants and Group (III) SH3 motif mutants. OECs were transfected with three series of mutant cDNAs: amino 
terminus deletion constructs (A-D), carboxyl terminus deletion constructs (E-G), SH3 motif mutants (H-J) and actin stained. Only pDK transfectants 
(J) gave a wild type distribution pattern.Montague et al. BMC Neuroscience 2010, 11:63
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the toxicity to the reagent, which was cell type variable.
Post-treatment, the cells were washed once in PBS, fixed
in pre-warmed 4% paraformaldehyde for ten min and
washed three times in pre-warmed PBS.
Immunostaining
The primary antibodies, mouse HA monoclonal antibody
IgG1HA.11 Clone16B12 (Convance) and mouse acety-
lated tubulin monoclonal antibody IgG2b (Sigma) were
used at 1: 5000 and 1: 500 respectively. Fixed and washed
coverslips as previously described were treated in cold
methanol for 10 min, washed three times in PBS and
treated overnight with primary antibody diluted in 1%
normal goat serum/PBS. The coverslips were rinsed three
times in PBS and treated with FITC and TRITC fluoro-
chrome-conjugated secondary antibodies (Southern Bio-
technique) at 1:100 diluted in PBS for 45 min at room
temperature. The coverslips were washed three times in
PBS, rinsed briefly in distilled water and mounted in
Vectashield with DAPI. The cells were visualized by fluo-
rescence microscopy (Zeiss Axioskop) using MetaMorph
image analysis from Molecular devices. For confocal
analysis of Mayven and actin expression OECs were visu-
alized using a Zeiss LSM 510 Meta equipped with a
multi-line Argon laser and two HeNe lasers.
Cytoskeletal staining
Actin was detected with Texas Red conjugated Phalloidin
(Invitrogen). The fixed cells were permeablised with
0.01% TritonX-100/PBS for five min at room tempera-
ture. Following three PBS washes the coverslips were
incubated with 1% BSA/PBS for 20 min at room tempera-
ture. Each coverslip was treated with 2.5 μl of a 6.6 μM
methanolic stock of Phalloidin Texas Red in 100 μl of 1%
Table 1: Sequence of PCR cloning primers
Construct Forward primer1 Reverse Primer 1
pMayven-EGFP (BglII)5'-AGATCTCCCACCATGGAGACGCCGCCGCTGCCT-3' (HindIII) 5'-AAGCTTTAATGGTTTATCAATAACTGT-3'
pΔSH3 (BglII) 5'-AGATCTCCCACCATGTGCACAAAGCAGGGTCATCAG-3' (HindIII) 5'-AAGCTTTAATGGTTTATCAATAACTGT-3' †
pΔFYN (BglII) 5'-AGATCTCCCACCATGAACGAACTAAGAAGTCAA-3' (HindIII) 5'-AAGCTTTAATGGTTTATCAATAACTGT-3' †
pΔBTB/POZ (BglII) 5'-AGATCTCCCACCATGGTCCTCCTCCCAGCAGCTGGC-3' (HindIII) 5'-AAGCTTTAATGGTTTATCAATAACTGT-3' †
pΔBACK (BglII) 5'-AGATCTCCCACCATGAACCTTCCCAAATTGATG-3' (HindIII) 5'-AAGCTTTAATGGTTTATCAATAACTGT-3' †
pΔKELCH (BglII)5'-AGATCTCCCACCATGGAGACGCCGCCGCTGCCT-3' † (HindIII) 5'-AAGCCTTTTGGGAAGGTTCATGGGTGT-3'
pΔKELCH-456 (BglII)5'-AGATCTCCCACCATGGAGACGCCGCCGCTGCCT-3' † (HindIII) 5'-AAGCCTACCTCCAACAACGCCAACGCC-3'
pΔKELCH-6 (BglII)5'-AGATCTCCCACCATGGAGACGCCGCCGCTGCCT-3' † (HindIII) 5'-AAGCCTACCATTAACTGCGCAGACACC-3'
pΔPPL (HindIII) 5'-AGATCTCCCACCATGCCTCCCGCATGCACAAAGCAG-3' (HindIII) 5'-AAGCTTTAATGGTTTATCAATAACTGT-3' †
pQA (HindIII) 5'-AGATCTCCCACC ATGGAGACGCAGCCGCTGCCTGCCGCA-3' (HindIII) 5'-AAGCTTTAATGGTTTATCAATAACTGT-3' †
pDK (HindIII)5'-AGATCTCCCACCATGGACAAGCCGCCGCTGCCTCCCGCA-3' (HindIII) 5'-AAGCTTTAATGGTTTATCAATAACTGT-3' †
pEGFP-Mayven (XhoI) 5'-CTCGAGATGGAGACGCCGCCGCTGCCT-3'. (HindIII) 5'-AAGCTTTAATGGTTTATCAATAACTGT-3'
pEGFP-ΔFYN (XhoI) 5'-CTCGAG-ATGAACGAACTAAGAAGTCAA-3'. (HindIII) 5'-AAGCTTTAATGGTTTATCAATAACTGT-3'
pMayven-HA (HindIII) 5'-AGCTTCCCACCATGGAGACGCCGCCGCTGCCT-3' (Kpn I) 5'-GGTACCTAATGGTTTATCAATAACTGT-3'.
1 Restriction enzyme sites are italicised and corresponding sequences are in bold. The artificial Kozak motif is underlined.
† Common primers used in the construction of the three sets of Mayven mutants.Montague et al. BMC Neuroscience 2010, 11:63
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BSA/PBS for 20 min at room temperature, rinsed three
times in PBS, twice in water and mounted in Vectashield
with DAPI. The microtubular network was stained with a
mouse monoclonal antibody raised against acetylated
tubulin (IgG2b, Sigma).
Pharmacolological perturbation of the OEC cytoskeleton
i) Cytochalasin B. Cytochalasin B (Sigma) which induces
microfilament disassembly was reconstituted as a 1 mM
stock in ethanol. OECs were seeded onto coverslips in the
presence of 0.5 μM cytochalasin B for 18 hr prior to a four
hr transient transfection. Post transfection, the medium
was aspirated, washed twice with PBS and incubated for a
further 14 hrs in the presence of 0.5 μM Cytochalasin B,
fixed and actin stained with Texas Red Phalloidin to
assess microfilament disruption.
ii) Wiskostatin. Wiskostatin blocks actin filament
assembly by inhibiting the formation of the Arp2/3 nucle-
ation complex. The drug was reconstituted as a 10 mM
stock. Transiently transfected OECs 24 hrs post transfec-
tion were treated with a range of Wiskostatin concentra-
tions up to 10 μM for 2 hrs, fixed and actin stained as
described elsewhere.
iii) Nocodazole. The microtubule depolymerisation
agent Nocodazole (Sigma) was reconstituted in DMSO as
a 10 mM stock. Transiently transfected OECs on cover-
slips 24 hrs post transfection were treated with 30 μM for
three hrs Nocodazole. The cells were fixed and immunos-
tained with the acetylated tubulin antibody to assess
microtubular breakdown.
Measurement of OEC process length
Relative process length expressed in terms of arbitrary
pixel unit values was measured using the NIH Image J
system. Measurements were confined to non-transfected
and transfected cells with a spindle like morphology
which had two or three well defined processes. The
length of each process from the centre of the nucleus to
the tip was recorded for each individual cell. The number
of process measurements for each grouping was as fol-
lows: 23 non-transfected cells, 12 wild type transfectants,
6 pDK transfectants and 75 mutant transfectants from a
pool comprising pQH, pΔSH3, pΔFYN, pΔBTB/POZ,
pΔBACK, pΔKELCH, pΔKELCH-456 and pΔKELCH-6.
The statistical significance was assessed by a One-way
Anova Test followed by a Dunnett's Multiple Comparison
Test.
Time-lapse microscopy
Transfectants were visualised over an 18 hr period.
Images were captured every 3 min using the Nikon
TE2000 time-lapse microscope that has a Nikon perfect
focus (PFS) and images acquired using Metamorph 7
software (Molecular Devices). OPCs were plated onto
PLL treated glass well dishes (Iwaki). When 50% conflu-
ent, the plate was positioned in a controlled temperature
and CO2 chamber, 20 cells were selected for time lapse.
Images were collected every 3 mins for 18 hrs and the
data converted to a movie (AVI format) or saved as indi-
vidual stack files using Metamorph.
Results
Subcellular distribution of exogenous Mayven in 
transfected neural and fibroblast cells
Previously we visualised Mayven localization in oligoden-
droglial lineage cells using an antibody [6] (a gift from S.
Avraham), however this was unavailable for further stud-
ies. For extended analysis on the subcellular distribution
of Mayven, we performed transient transfections on the
morphologically plastic and highly process forming
OECs. Transfection efficiencies varied between 15 and
40%. Routinely, well over 50% of pMayven-EGFP trans-
fectants had intense regions of EGFP activity positioned
towards the process tips overlapping in part with lamelli-
podial actin (Fig. 3A) similar to the distribution pattern
described in OPC transfectants [7]. Variable somal stain-
ing was also observed. Soma and process staining was
more uniform in transfectants lacking these regions of
accumulated Mayven in the tips. This process enriched
distribution pattern was also obtained following co-trans-
fection of pMayven-HA and pEGFP-Actin confirming
exogenous Mayven transport and accumulation in the
process tips is relatively unaffected by the nature or
length of the conjugated reporter (Fig. 3A,B). Mayven
was clearly absent from the more fine filipodial exten-
sions and does not define the membrane boundary of
OEC lamellipodium (Fig. 3A,B). This contrasted to the
distribution of exogenous Lasp-1, an actin binding pro-
tein in which does demarcate the lamellipodial mem-
brane as depicted in pMayven-HA and pLasp-EGFP co-
transfectants (Fig. 3C).
A similar subcellular distribution was also obtained in
other neural Mayven transfectants including, Schwann
cells, astrocytes, the OPC line Oli-Neu, in addition to the
neuroblastoma cell line B104 (Fig. 3D-G). The yellow flu-
orescence in these merged images depicts a modest and
variable degree of overlap between exogenous Mayven
and actin towards the process tips. In contrast to neural
transfectants, there was no evidence of an accumulation
of the fusion protein proximal to cortical actin in tran-
siently transfected Cos7 cells. In this highly vacuolated
large rounded fibroblast cell type, staining was more peri-
nuclear and punctate in appearance (Fig. 3H). In trans-
fected BHK fibroblasts which have a more asymmetric
cell morphology with processes, Mayven distribution was
uniform in nature and did not overlap with cortical actin
(Fig. 3I). This stark difference in the distribution pattern
between the neural and non-neural transfected cells cor-
responds to their comparative endogenous MayvenMontague et al. BMC Neuroscience 2010, 11:63
http://www.biomedcentral.com/1471-2202/11/63
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mRNA levels. Fig. 4 is a RT.PCR image depicting endoge-
nous message activity relative to the house keeping mes-
sage Cycophilin. Mayven mRNA signal intensity in Cos7
and BHK cells (Fig. 4, lanes 6 and 7) is relatively low even
at a high cycle number (x35) compared to the message
abundance in the neural cells which also display some
variation (Fig. 4, lanes 1-5).
Confocal micrographs were captured for a more
detailed analysis of Mayven and actin localization in OEC
transfectants. These essentially mirror the epifluoresence
images (Fig. 3) confirming a modest degree of Mayven
and actin overlap towards the leading edge of the lamelli-
podium (Fig 5A,B) suggestive of co-localization of these
proteins as reported in OPC transfectants [7]. In addi-
tion, the confocal images clearly show that Mayven does
not demarcate the lamellipodial membrane.
Cytoskeletal integrity and the subcellular location of 
exogenous Mayven
To investigate any relationship between Mayven location
in the lammelipodium of OEC transfectants and the
Figure 5 Cofocal analysis depicting the relationship between the 
subcellular distribution of Mayven and actin in OEC transfectants. 
OECs were transiently transfected with pMayven-EGFP and actin 
stained. Mayven is transported towards the lamellipodia in both flat (A) 
and (B) spindle cells and overlaps in part with actin in both cell types 
as highlighted in the blow ups.
Figure 4 RT.PCR depicting endogenous Mayven message levels 
in neural and non-neural cells. Mayven (Product length 1323 bps) 
and Cyclophilin (Product length 300 bps) were amplified from cDNAs 
prepared from O2A c-myc (OPC), (OECs), astrocytes (Ast), Schwann 
cells (Sc), (B104), (Cos7) and (BHK). Mayven mRNA abundance is much 
higher in neural cell types.
Figure 3 Subcellular distribution pattern of exogenous Mayven in neural and non-neural cells. (A) pMayven-EGFP/OECs, (B) (pMayven-HA/
pEGFP-βActin)/OECs, (C) (pMayven-HA/pLasp-EGFP)/OECs. (D) Schwann cells, (E) astrocytes, (F) Oli-Neu cells, (G) B104 cells, (H) Cos7 cells and BHK 
cells (I) were transiently transfected with pMayven-EGFP and actin stained. Mayven is transported to the tips and overlaps in part with actin in all neural 
cell types (A-I) in contrast to the distribution pattern in Cos7 and BHK transfectants (H,I).Montague et al. BMC Neuroscience 2010, 11:63
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integrity of the cytoskeleton, changes in exogenous May-
ven distribution was tracked following pharmacological
perturbation of the OEC cytoskeleton following treat-
ment with i) Cytochalasin B, ii) Wiskostatin and iii)
Nocodazole.
i)  Cytochalasin B Cytochalasin B is a cell permeable
fungal toxin that blocks actin monomer addition at the
fast growing end of polymers leading to a concentration
dependent disruption of the actin cytoskeleton. Song and
colleagues reported that treatment of 3 day old OPC cul-
tures with 0.2 μM Cytochalasin B for 36 hrs led to disas-
sembly of the microfilaments accompanied by severely
compromised normal process outgrowth and branching
[31]. Adopting these guidelines, we found that adminis-
tration of a 0.5 μM concentration to a one day old OEC
culture for 36 hrs resulted in a general breakdown of the
actin cytoskeleton, most notably in the processes of the
spindle like cells (Fig. 6A,B). Drug treated cells trans-
fected with pMayven-EGFP had a different subcellular
distribution pattern from control transfectants with a
relocation of Mayven from the process tips to the soma as
depicted in the representative image (Fig. 6C). At this
Cytochalasin B concentration, the number of process
positive staining transfected cells fell to background level
o f  ar ound ≤ 0. 1%.  In c o n t ras t,  t he r e  was no  obse rva ble
change in the subcellular location of EGFP in pEGFP-N1
transfected cells, a protein not generally associated with
the microfilament component (Fig. 6D). This trend was
reproducible (n ≥ 3) suggestive of an intimate relationship
between these regions of accumulated Mayven in the
process tips and an intact actin cytoskeleton.
ii) Wiskostatin Wiskostatin inhibits formation of an
active Arp2/3 complex without disrupting the overall
integrity of the actin cytoskeleton [32]. Bacon et al [2] had
previously shown that administration of 10 μM Wiskosta-
tin to proliferating Schwann cells resulted in the complete
retraction of process outgrowth after 30 min. In addition,
process extension was fully blocked following drug treat-
ment of freshly seeded Schwann cells. However the spec-
ificity of this drug to target Arp2/3 inhibition was the
focus of a recent study [33] reporting that at critical con-
centrations, Wiskostatin treatment also reduces cellular
ATP levels leading to an irreversible effect which in turn
severely impacts on general cell function including viabil-
ity.
Taking cognisance of this and using drug concentra-
tions described for Schwann cells [2] pMayven-EGFP and
pEGFP-N1 transfected OECs were administered a range
Wiskostatin concentrations from 0.5 μM - 10 μM for 2
hrs and assessed for any changes in the Mayven distribu-
tion pattern. At concentrations up to 2 μM, there was no
evidence of cytotoxicity [33] or any discernible alteration
in the integrity of the actin cytoskeleton. At this concen-
tration there was no significant drop in the number of
process tip positive cells (Fig. 6E). Although increasing
drug level to 4 μM had no measurable cytotoxic effect, it
led to a marked reduction in the number of Mayven posi-
tive cells compared to 2 μM treated transfectants. In par-
allel, there was a corresponding increase in the number of
somal staining cells indicative of a possible redistribution
of the protein from the process tips in drug treated cells
(Fig. 6F). At higher drug concentrations (5-10 μM) there
was a significant increase in the number of rounded dying
c e l l s  p r e s u m a b l y  c a u s e d  b y  t h e  n o n - A r p 2 / 3  e f f e c t  o f
Wiskostatin [33] (Fig. 6G). This concentration correlated
with the complete absence of process tip positive cells. In
contrast to Mayven tranfectants, the distribution pattern
in OECs transfected with the control vector pEGFP-N1
was invariant with increasing Wiskostatin concentrations
(Fig. 6H). These reproducible findings (n = 3) although
not confirming a functional association between Mayven
and an active Arp2/3 complex may infer an indirect rela-
tionship between inhibition of process extension and
Mayven localization.
iii) Nocodazole Nocodazole is an anti-mitotic drug that
binds to β-tubulin which leads to the inhibition of micro-
tubule assembly. Staining non-treated cells with an acety-
lated tubulin antibody which binds to an α-tubulin
epitope confirmed strong microtubular staining around
the perinuclear region and the more proximal areas of the
processes (Fig. 6I). Following guidelines we previously
described for Nocodzole treatment of Cos7 transfectants
[34] we found that OECs exposed to 30 μM Nocodazole
for 3 hrs lead to depolymerisation of the microtubular
network as evidenced by the breakdown of the character-
istic trebecular staining pattern in the vast majority of the
treated cells (Fig. 6J). There was no significant change in
the subcellular localization of exogenous Mayven in
Nocodazole treated transfected population (Fig. 6K,L).
This reproducible trend (n ≥ 3) suggests that although the
microtubular network provides mechanical stability to
the extending lamellipodium, its drug induced disruption
of this important cooperative interaction between the
microtubular and microfilament component had no dis-
cernible effect on the short term localization of Mayven.
Subcellular distribution pattern following expression of 
Mayven domain deletion mutants
OECs transfected with pMayven-EGFP gives rise to a well
defined subcellular localization pattern characterised by
regions of accumulated exogenous Mayven towards the
process tips (Fig. 3A; Fig. 5A,B). To identify specific
domain elements involved in the transport of exogenous
Mayven from the cytoplasm to the process tips, we have
tracked the subcellular destination of EGFP tagged May-
ven following transient transfection of OECs with a panel
of amino and carboxyl domain deletion mutants (Fig.
2(i,ii)). Deletion of the SH3 motif (pΔSH) resulted in aMontague et al. BMC Neuroscience 2010, 11:63
http://www.biomedcentral.com/1471-2202/11/63
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uniform staining pattern (Fig. 2(i),A). Excluding the
nucleus, EGFP activity was present throughout the cell
body and the proximal end of the processes. The intense
regions of staining corresponding to loci of accumulated
Mayven along the processes, characteristic of wild type
transfectants, were absent. There was no overlap with
actin. A similar trend was observed following transfec-
tion with pΔFYN and pΔBTB/POZ (Fig. 2(i),B,C). Com-
plete deletion of the amino terminus (pΔBACK) resulted
in a nuclear and somal signal pattern accompanied with
weak EGFP signal in the proximal end of the processes
(Fig. 2(i),D). These findings suggest that the accumula-
Figure 6 Subcellular distribution pattern of exogenous Mayven following drug induced disruption of the OEC cytoskeleton with Cytocha-
lasin B (A-D), Wiskostatin (E-H) and Nocodazole (I-L). Non-transfected (A,B) pMayven-EGFP (C) and pEGFP-N1 (D) transfected cells were exposed 
to 0.5 μM Cytochalasin B for 36 hrs (B-D) and stained for actin (A-D). Cytochalasin B treatment resulted is a redistribution of Mayven (C) compared to 
EGFP (D). Transfected pMayven-EGFP cells were administered 2, 4 and 8 μM Wiskostatin for 2 hrs (E-G) and pEGFP-N1 cells were treated for the same 
duration with 8 μM (H). In the absence of cell death there was a relocation of Mayven (F) while cell death did not accompany any change in the dis-
tribution pattern in pEGFP-N1 transfectants (H). Non-transfected cells (I,J) and pMayven-EGFP transfected cells (K,L) were treated with 30 μM Nocoda-
zole for up to 3 hrs (J,L) and immunostained for β-tubulin (I-L). Mayven loclaization remains unaffected despite a breakdown in the microtubular 
network (K,L).Montague et al. BMC Neuroscience 2010, 11:63
http://www.biomedcentral.com/1471-2202/11/63
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tion of exogenous Mayven at the distal end of the pro-
cesses is dependent upon the presence of the SH3 motif
of the Fyn Kinase binding domain. However, expression
of the carboxyl mutant pΔKELCH, encoding the com-
plete amino terminus did not produce the wild type pat-
tern, localization of this truncated Mayven protein was
nuclear and somal (Fig. 2(ii),E) similar to that observed in
pBACK transfectants (Fig. 2(i),D). Expression of recom-
binants pΔKelch-456 and pΔKelch-6 encoding three and
five Kelch units respectively gave a distribution profile
(Fig. 2(ii),F,G) resembling the amino mutants pΔSH3,
pΔFYN and pΔBTB/POZ (Fig. 2(i), A-C). In conclusion,
the accumulation of Mayven in the process tips is depen-
dent on the presence of a SH3 motif and the six units
comprising the Kelch domain. This pattern in distribu-
tion between wild type and mutant forms was observed
in other glial transfectants and in the B104 cell line but
not in transfected Cos7 or BHK cells (data not shown).
Expression of SH3 mutants compromises exogenous 
Mayven subcellular localization
Expression studies with pΔSH3 demonstrated that com-
plete deletion of the proline rich SH3 motif (PPLPPA) of
the putative Fyn Kinase binding domain disrupts the sig-
nature wild type distribution pattern (Fig. 2A). T o iden-
tify critical sequences within the SH3 motif associated
with this phenotype, three mutants were assayed (Fig.
2(iii)). Removal of the first three residues (pΔPPL) of the
motif resulted in a similar pattern to pΔSH3 (Fig. 2H). A
mutant phenotype was also observed following expres-
sion of pQA carrying two proline substitutions
(QPLAPA) in the motif (Fig. 2I). In contrast, transfection
with pDK, a mutant with an intact SH3 motif but with a
double amino acid substitution between the initiation
codon and the SH3 motif gave a localization pattern
indistinguishable from wild type Mayven cDNA (Fig. 2J).
This trend was maintained in other transfected neural
cells but not in Cos7 or BHK transfectants (data not
shown).
Wild type and mutant process length and dynamics
A reproducible observation from a series of OEC trans-
fections was that all Mayven mutants except pDK had a
similar subcellular distribution phenotype (Fig. 2ii) and
that these transfectants appeared to have shorter pro-
cesses than transfectants expressing the wild type form or
pDK. For this reason we performed an analysis to quan-
tify this perceived trend. A relative comparison of process
length using Image J software was undertaken. The ratio-
nale for this pooling strategy was to test the prediction
that this common mutant distribution phenotype may
reflect a general reduction in process length. Analysis was
made from images ca ptured from 75 mutant cells tha t
had successfully been transfected over several experi-
ments and comprised of cells transfected with pQH (7
cells), pΔSH3 (9 cells), pΔFYN (9 cells), pΔBTB/POZ (6
cells), pΔBACK (12 cells), pΔKELCH (11 cells),
pΔKELCH-456 (13 cells) and pΔKELCH-6 (8 cells).
Transfected and adjacent non-transfected cells with a
spindle like morphology with well defined processes were
selected. Mutant process length values were pooled and
compared to a non-transfected population (23 cells) and
pDK (6 cells). As depicted in Fig. 7 there was a statistical
significant (P < 0.001) difference of around 40% in pro-
cess length between non-transfected cells and the pool of
mutants. In contrast, a comparison of the non-trans-
fected mean values with those of pMayven-EGFP and
pDK did not reveal any significant difference in the aver-
age process length between these groupings.
Time lapse recording of Mayven wild type and mutant
transfectants are shown in supplemental data. In Addi-
tional file 1 OPCs were transfected with pEGFP-N1.
EGFP is localized throughout the cell delineating the
entire cell and is not concentrated in the processes. Con-
versely in Additional file 2 a typical OPCs transfected
with wild type Mayven shows intense staining in the tips
which can be seen to move along the process during time
lapse. An example of one of the Mayven mutants
(pΔFYN) can be seen in Additional file 3. In this case,
Mayven distribution is less intense and is absent from the
process tips making the cell appear quite small. These
recordings are selected images from the time lapse
recording spaced apart by 5 min.
Figure 7 Relative process length between non-transfected OECs 
compared to pMayven, pDK, and a pool of mutant transfectants. 
Compared to non-transfected cells there is a significant reduction in 
process length in the pool of mutant transfectants.Montague et al. BMC Neuroscience 2010, 11:63
http://www.biomedcentral.com/1471-2202/11/63
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Differing roles for the BTB/POZ and BACK domains in 
exogenous Mayven transport
Co-expression experiments with pMayven-HA cDNA
(Texas Red) and the various Mayven -EGFP mutants
(FITC) afforded an opportunity to compare the subcellu-
lar distribution between wild type and mutant forms of
Mayven in the same transfected OEC cell. Transient co-
transfection with Mayven-HA cDNA and the SH3
mutant plasmids pΔSH3, pΔPPL, pQA in addition to
pΔFYN gave a somewhat unexpected finding in that the
EGFP tagged mutant form of the protein overlapped with
the HA tagged wild type form as evidenced by the yellow
fluorescence in the merged images (Fig. 8A,B) depicting
pΔSH3 and pΔFYN co-transfectants respectively. In con-
trast, there was no evidence of "phenotypic rescue" via
protein interaction between wild type and mutant forms
following co-transfection with pΔBTB/POZ or pΔBACK.
Fig. 8C,D shows a strict demarcation of the HA tagged
Mayven at the process tips and the EGFP-mutant protein
in the cytoplasm. Both of these constructs lack the BTB/
POZ domain which has been reported to mediate homo-
dimerization of Mayven [8].
However why the proteins encoded by pΔSH3 and
pΔFYN mutants are retained in the soma in the presence
of endogenous Mayven (Fig. 2(ii)) but are rescued upon
supplementation with exogenous HA tagged Mayven as
evidenced in the co-transfection experiments (Fig. 8A,B)
requires explanation. Although variable, the presence of a
high cDNA copy number following a transient transfec-
tion generally results in a higher abundance of exogenous
protein compared to its endogenous form. This observa-
tion in part may explain the apparent failure to affect a
"phenotypic rescue" arising from the interaction between
endogenous Mayven and the EGFP tagged exogenous
proteins encoded by pΔSH3 and pΔFYN plasmids. In co-
transfected cells, the abundance of wild type HA-tagged
Mayven and EGFP-mutant forms are predicted to around
equimolar allowing detectable interaction ie "phenotypic
rescue". In contrast, endogenous Mayven levels in mutant
transfectants are much lower and consequently are
unable to dimerize via their respective BTB/POZ
domains in sufficient numbers to elicit a detectable "phe-
notypic rescue". This is consistent with RT.PCR evidence
depicting Mayven message levels between control cells,
pΔBTB/POZ and pΔFYN transfectants (Fig. 8E lanes 1-3)
which show a significant increase in Mayven message lev-
els in the transfected cells following gel loading adjust-
ment to the two house keeping mRNAs Cyclophilin and
β-Actin. Moreover, this exogenous:endogenous ratio
between transfected and control cells at the individual
cell level will be significantly greater than the ratios
depicted in the RT.PCR (Fig. 8E) when the transfection
rate is considered.
Discussion
Exogenous Mayven subcellular localization and the OEC 
cytoskeleton
Several lines of evidence suggest that Mayven, an actin
binding, multi-domain protein member of the BTB-
BACK-Kelch family has a key role in oligodendroglial
process extension [6,7].
We found that OECs transfected with wild type May-
ven-EGFP cDNA gave a similar pattern to the subcellular
localization of endogenous Mayven in oligodendrocytes
overlapping in part with lammelipodial actin [6,7].
Although OECs are distinct from other macroglia, they
share many molecular characteristics with Schwann cells
[24,35] and provided appropriate cellular cues are pres-
ent, OECs can myelinate axons [36]. Furthermore, it has
been shown that OECs have morphological plasticity
with extensive process formation [3,4]. Allied to the high
transfection rate compared to oligodendroglial lineage
cells, we consider OECs to be an appropriate cell type to
monitor exogenous Mayven transport.
A combination of endogenous and exogenous Mayven
and actin co-localization studies, together with a series of
co-immunoprecipitations experiments provide compel-
ling evidence that Mayven is an actin binding protein [6-
8]. Our Cytochalasin B studies suggest a close association
between the integrity of the actin cytoskeletal network
and Mayven localization in the process tips. The assem-
bly and depolymerisation of actin filaments and organiza-
tion into functional higher order networks evident in
lamellipodia and filipodia is ultimately regulated by a het-
Figure 8 Subcellular distribution pattern of exogenous Mayven 
following co-expression of a series of pMayven-EGFP amino dele-
tion mutants with pMayven-HA and RT.PCR comparing endoge-
nous and exogenous Mayven message levels in non-transfected 
and transfected OECs. OECs were co-transfected with pMayven-HA 
and mutant constructs pΔSH3 (A), pΔFYN (B), pΔBTB/POZ (C) and 
pΔBACK and immunostained for HA. Homomeric interaction (A,B) be-
tween the wild HA tagged fusion protein and EGFP tagged mutant 
form was dependent on the presence of a BTB/POZ domain. (E) RT. 
PCR Mayven (Product length 1323 bps) Cyclophilin (Product length 300 
bps), β actin (146 bps) were amplified from cDNAs prepared from non-
transfected OECs (lane 1), pΔBTB/POZ transfectants (lane 2) and 
pΔFYN transfectants (lane 3) confirming an increase in Mayven mRNA 
levels in transfected cells.Montague et al. BMC Neuroscience 2010, 11:63
http://www.biomedcentral.com/1471-2202/11/63
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erogeneous group of actin binding proteins (ABPs). It is
interesting to speculate whether Mayven can be ascribed
to a particular class of ABPs from its subcellular distribu-
tion pattern. Lamellipodial actin is assembled in part by
crosslinking proteins like spectrin and filamin which
arrange actin filaments into orthogonal arrays [37]. How-
ever, Mayven lacks the typical domain organization asso-
ciated with this ABP grouping and since Mayven only
partially overlaps with lamellipodial actin, may argue
against Mayven's inclusion in this class of ABPs. Another
group of ABPs for consideration are the sidebinders and
signallers such as Cortactin and ENA/VASP [37]. Like
Mayven, these are multi-domain proteins that interact
with other proteins within signalling networks resulting
in cytoskeletal remodelling. The presence of the Fyn
Kinase binding domain supports its candidacy for this
ABP grouping.
ABPs have a crucial role in actin nucleation via forma-
tion of the Arp2/3 complex. Immunostaining evidence
has confirmed that the Arp2/3 component protein p34
and polypeptides crucial to its activation most notably,
N-WASP, WAVEs, Cdc42 and Rac localize close to the
oligodendrocyte and Schwann cell membrane [2] con-
trasting with Mayven's absence from the protruding
lamellipodial membrane. We found that treatment of
pMayven-EGFP and pEGFP-N1 OEC transfectants with
low concentrations of the Arp2/3 inhibitor Wiskostatin,
resulted in a redistribution of Mayven compared with an
unaltered EGFP pattern. At this Wiskostatin concentra-
tion, there was no evidence of cell death arising from the
non-specific of the drug leading to a reduction in cellular
ATP levels [33].
Although the microfilament and the microtubular net-
works have distinct functions and a well defined subcellu-
lar distribution patterns, there is a growing body of
evidence supportive of a coordinated relationship
between the two major cytoskeletal components medi-
ated by signalling pathways using common regulators
most notably the GTPases [38,39]. However, our findings
suggest that depolymerization of the microtubules fol-
lowing administration of Nocodazole had no significant
effect on the subcellular distribution of Mayven in OEC
transfectants concluding that Mayven is unlikely to be
involved in these important cytoskeletal coordinated
events.
Following this speculation on Mayven function based
on lamellipodial localization, its absence from filipodia
and the outer membrane of oligodendrocytes [6,7] may
provide inferred evidence to rule out certain biological
functions for Mayven. Actin within the filipodia is orga-
nized in parallel bundles and provides the initial anchor-
age points on the axon prior to ensheathment [40] which
would seem to uncouple Mayven function from axonal
contact.
Wild type and mutant subcellular distribution pattern
To identify domain or sub-domain regions involved in the
subcellular distribution of Mayven we transfected OECs
with the panel of EGFP tagged Mayven mutants. Only
cells transfected with pDK, which carries two point
mutations between the initiation codon and the SH3
motif which gave a wild type distribution pattern. Expres-
sion of all other mutants confirmed Mayven was present
throughout the soma and in the nucleus of pΔBACK and
pΔKELCH transfectants. Signal also extended to the
more proximal regions of the processes. This pancellular
appearance is similar to the distribution profile observed
in the control vector pEGFP-N1 transfectants. This may
be regarded as the default transport pattern or non-spe-
cific diffusion of this foreign protein. Although fusion
proteins derived from expression of mutant cDNAs are
present in the processes, they maybe unable to interact
with their binding partners as evidenced by the absence
of intense staining regions characteristic of the wild type
form. This difference in localization may have functional
significance. It is intriguing that this relationship between
the similarity in the distribution pattern of exogenous
Mayven in OECs transfected with wild type and pDK
with mutant transfectants mirrors their respective differ-
ences in their process lengths. This dominant negative
effect observed with our panel of Mayven mutants, is
consistent with our earlier study reporting a reduction in
process length in OPCs transfected with a c-myc tagged
Mayven mutant lacking the SH3 motif [6].
The static transfectant images presented in our study
depicting the uniform distribution of exogenous Mayven
in OECs transfected with each Mayven mutant (except
pDK) contrasts with the characteristic wild type pattern
with regions of accumulated Mayven in the process tips.
Time-lapse experiments performed with O2A-cmyc wild
type transfectants confirm that these regions of accumu-
lated Mayven are intimately involved in process motility
and extension. The absence of these accumulated regions
in mutant transfectants coincides with compromised
motility and extension.
However, our findings are inconsistent with a previous
study on the transfection of two amino tagged EGFP
mutants in an OPC background [7]. Expression of these
truncated constructs, pEGFP-SH3-FYN-BTB/POZ and
pEGFP-BTB/POZ lack the BACK-KELCH region which
is present in our equivalent recombinants (Fig 6(i),(ii))
co-localized with actin The other main difference
between both sets of deletion mutants is the relative ori-
entation of the EGFP moiety. However, we found no dif-
ference, following expression of pEGFP-ΔFYN and
pΔFYN-EGFP (data not shown). Direct comparison with
our findings and this study [7] is difficult as the wild type
subcellular distribution pattern is not described.Montague et al. BMC Neuroscience 2010, 11:63
http://www.biomedcentral.com/1471-2202/11/63
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Mayven function: Multi-protein complex formation
Although the Mayven gene is expressed in a wide range of
cell types throughout development, transcript levels are
enriched in the CNS with some regional variation in
brain tissue [8]. To date, as there is no evidence of splice
variants, whether the gene is expressed in the oligoden-
drocyte, the OEC or the hepatocyte, the Mayven poly-
peptide is predicted to have the same structural domain
organization (Fig. 1A). Thus, it is likely that Mayven's
functional diversity is dependent on how the individual
domains react and cooperate with binding partners,
which will vary with cellular background. This is sup-
ported by our observations that exogenous Mayven has a
different subcellular localization between neural and non
neural cells (Cos7 and BHK fibroblasts). This, allied to
low endogenous mRNA levels suggest that Mayven func-
tion, if any, in these cells differs from Mayven function in
neural cells. Co-localization evidence and immunopre-
cipitation studies confirm a close association/interaction
between Mayven and Fyn Kinase in OPCs [7]. The non-
polarized distribution of exogenous Mayven in these
fibroblasts maybe related to the relatively low levels of
endogenous Fyn Kinase in Cos7 cells [41] and contrasts
with the higher abundance in glial cells [42]. Accordingly,
this predicted imbalance between exogenous Mayven and
endogenous Fyn Kinase in Cos7 transfectants may impact
on the subsequent distribution pattern of Mayven and its
absence from cortical actin.
A significant increase in Mayven  gene expression
between breast epithelia and corresponding tumour tis-
sue has been reported [43]. This led to an induction of c-
jun levels resulting in cell division following cyclin D1
activation via the JNK pathway. Using a series of Mayven
d o m a i n  r e p o r t e r  c o n s t r u c t s  r e v e a l e d  t h a t  t h i s  c a s c a d e
was mediated by the BTB/POZ domain. In a more recent
study NAC1, which encodes a BTB/POZ domain acts as a
co-repressor for other BTB/POZ proteins in the mature
CNS was shown to bind to Mayven via heteromeric inter-
action between their respective BTB/POZ domains [44].
Consistent with our findings on the role of the BTB/POZ
in Mayven dimerization and in the rescue of Mayven
mutant phenotypes, is the study by Soltysik-Espanola and
colleagues using a cross-linking agent to assess protein
interaction under reducing and non-reducing conditions
concluding that Mayven was capable of dimerization in
solution [8].
We propose that Mayven localizes to the lamellipodium
proximal to a series of other proteins that appear to share
a key role in neural process formation by actin polymer-
ization driven membrane protrusion. As depicted in the
schematic (Fig. 9) Mayven has a domain organization
with the predicted capacity to self-associate via its BTB/
POZ domain forming Mayven dimers or complex with
other BTB/POZ proteins such as NAC1 [44] and interact
with higher order actin structures and other binding
partners through its Kelch domains to form different
multi-protein complexes with a range of as yet unknown
function. In a glial background, Mayven may be involved
through its Fyn Kinase binding domain, with integrin
activated signalling cascades involving Fyn Kinase and
the small GTPase family members, RhoA, Rac1 and
Cdc42 [19,20] linking extracellular stimuli to changes in
the organization of the cytoskeleton via Arp2/3 activa-
tion.
Conclusions
Generation of this panel of Mayven mutants has illus-
trated important properties of three domains in the loca-
tion of Mayven along cell processes and their possible
functional roles in process extension. For example
recruitment of Mayven to the leading edge of neural cell
lamellipodia requires the presence of a wild type SH3
motif of the putative Fyn Kinase binding domain at the
amino terminus and a full complement of the six units
comprising the Kelch domain. In addition the BTB/POZ
domain appears to be important in homomeric interac-
tions. Lastly the subcellular localization of exogenous
Mayven is reliant upon the presence of an intact actin
cytoskeleton.
Additional material
Additional file 1 Time lapse recording of pEGFP O2A-cmyc cells. Trans-
fectants were visualised over 18 hr period and images collected every three 
min using a Nikon TE2000 with perfect focus. It can be seen that the entire 
cell is filled with fluorescence.
Additional file 2 Time lapse recording of pMayven-EGFP O2A-cmyc 
cells. Transfectants were visualised over 18 hr period and images collected 
every three min using a Nikon TE2000 with perfect focus. EGFP Mayven can 
be seen to move along the tips of the cells.
Additional file 3 Time lapse recording of a SH3 mutant Mayven-EGFP 
in O2A-cmyc cells. Transfectants were visualised over 18 hr period and 
images collected every three min using a Nikon TE2000 with perfect focus. 
In this mutant Mayven remain perinuclear and can not be seen to be trans-
ported in the cell processes.
Figure 9 Schematic depicting proposed individual domain func-
tion in Mayven multi-protein complex formationMontague et al. BMC Neuroscience 2010, 11:63
http://www.biomedcentral.com/1471-2202/11/63
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